Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis

BACKGROUND: It is unclear whether hepatocyte function and/or portal hypertension improves if a sustained virologic response (SVR) is achieved with direct-acting antivirals in patients with decompensated hepatitis C-related cirrhosis. METHODS: We examined the safety and efficacy of a 12-week course o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotani, Kohei, Enomoto, Masaru, Uchida-Kobayashi, Sawako, Tamori, Akihiro, Yukawa-Muto, Yoshimi, Odagiri, Naoshi, Motoyama, Hiroyuki, Kozuka, Ritsuzo, Kawamura, Etsushi, Hagihara, Atsushi, Fujii, Hideki, Kageyama, Ken, Yamamoto, Akira, Yoshida, Atsushi, Higashiyama, Shigeaki, Kawabe, Joji, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article―Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049944/
https://www.ncbi.nlm.nih.gov/pubmed/36729172
http://dx.doi.org/10.1007/s00535-023-01963-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049944/
https://www.ncbi.nlm.nih.gov/pubmed/36729172
http://dx.doi.org/10.1007/s00535-023-01963-2

Ejemplares similares